956116-90-8
Chemical Structure
Pitavastatin magnesium
- CAS No.: 956116-90-8
- Formula:C50H43F2MgN2O8
- Molecular Weight:862.19
IUPAC Name: magnesium(V) (E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dioxidohept-6-enoate (E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-5-hydroxy-3-oxidohept-6-enoate
InChIKey: RABUBZNBEXPHFM-WUVPNHNWSA-L
SMILES: [O-]C(CC1O[Mg+2](OC(CC2=O)CC(O)/C=C/C3=C(C4=CC=C(F)C=C4)C5=C(C=CC=C5)N=C3C6CC6)([O-]2)OC(C1)/C=C/C7=C(C8=CC=C(F)C=C8)C9=C(C=CC=C9)N=C7C%10CC%10)=O
Biological Activity: Pitavastatin magnesium is an orally active HMG-CoA Reductase inhibitor. Pitavastatin magnesium lowers total cholesterol and low-density lipoprotein cholesterol in a hyperlipidemic rat model. Pitavastatin magnesium can be used in research on cardiovascular and cerebrovascular diseases such as hyperlipidemia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pitavastatin magnesium | 99.76% | Pitavastatin magnesium is an orally active HMG-CoA Reductase inhibitor. Pitavastatin magnesium lowers total cholesterol and low-density lipoprotein cholesterol in a hyperlipidemic rat model. Pitavastatin magnesium can be used in research on cardiovascular and cerebrovascular diseases such as hyperlipidemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Pitavastatin magnesium (Zypitamag) for hyperlipidemia. Med Lett Drugs Ther. 2018 Jun 18;60(1549):106. [Content Brief]
- [2]. Abolhasani S, et al. Pitavastatin-induced cholesterol deficiency elevates serum biomarkers associated with statin-related adverse effects in rats. Cardiovasc Endocrinol Metab. 2025 Mar 7;14(2):e00326. [Content Brief]
